Network meta-analysis of randomized controlled trials evaluating long-term outcomes of interventional approaches for great saphenous vein insufficiency.

J Vasc Surg Venous Lymphat DisordJun 15, 2026 (epub)
Clinical ResearchVascular SurgeryOpen access

Fan Maitri Aldian, Yan Efrata Sembiring, Visuddho Visuddho et al.

✦ AI-curated · Sources linked

In 30 seconds

This network meta-analysis evaluated long-term outcomes of interventions for great saphenous vein (GSV) insufficiency in 7913 cases from 33 randomized controlled trials. High ligation and stripping (HL&S) demonstrated significantly higher long-term freedom from failure compared to cyanoacrylate closure, endovenous laser ablation, and radiofrequency ablation, with hazard ratios ranging from 1.98 to 2.64 (P < .001).

Key findings

  • HL&S had a higher long-term freedom from failure compared to cyanoacrylate closure (HR, 1.98; P < .001).
  • Electrocoagulation showed the lowest Venous Clinical Severity Score at 6 months (mean difference, -0.59; P = .03).
  • Minimally invasive interventions allowed a faster return to normal activities compared to HL&S (P < .001).
  • HL&S had a higher proportion of ecchymosis (76.37%) and infection (2.35%) compared to ablation procedures.

Why it matters

Understanding the long-term efficacy and safety of various interventions for GSV insufficiency is crucial for optimizing treatment strategies and improving patient outcomes. This analysis provides valuable insights for clinicians in making informed decisions.

Source

Published in J Vasc Surg Venous Lymphat Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Vascular Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.